Pharvaris (PHVS) Assets Average (2021 - 2026)
Pharvaris (PHVS) reported Assets Average of $327.5 million for Q1 2026, up 14.46% on a YoY basis from $286.1 million in Q1 2025, and down 12.32% quarter-over-quarter from $373.5 million in Q4 2025.
Pharvaris (PHVS) Assets Average (2021 - 2026) Analysis & Trends
Pharvaris has reported Assets Average for 6 years, with the latest figure at $327.5 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 14.46% year-over-year to $327.5 million; the trailing twelve-month figure through Mar 2026 stood at $327.5 million (up 14.46% YoY), and the FY2025 full-year result was $328.0 million, down 12.15% from the prior year.
- Assets Average for Q1 2026 stood at $327.5 million, down from $373.5 million in the prior quarter.
- The five-year high for Assets Average was $419.6 million in Q1 2024, with the low at $164.9 million in Q1 2023.
- Historically, Assets Average has averaged $280.2 million across 5 years, with a median of $286.1 million in 2025.
- Annual changes were most pronounced in 2024 — Assets Average soared 154.47% — and 2025, when it plunged 36.84%.
- Pharvaris' Assets Average stood at $187.9 million in 2022, then jumped by 63.21% to $306.7 million in 2023, then rose by 6.85% to $327.6 million in 2024, then increased by 14.01% to $373.5 million in 2025, then fell by 12.32% to $327.5 million in 2026.
- The last three Assets Average figures came in at $327.5 million (Q1 2026), $373.5 million (Q4 2025), and $316.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 660.38 Mn |
| 10 | Pharvaris | 28.66 Bn | 28.37 Bn | - | 327.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 327.53 Mn |
| Dec 31, 2025 | 373.55 Mn |
| Sep 30, 2025 | 316.84 Mn |
| Jun 30, 2025 | 249.22 Mn |
| Mar 31, 2025 | 286.15 Mn |
| Dec 31, 2024 | 327.65 Mn |
| Sep 30, 2024 | 361.42 Mn |
| Jun 30, 2024 | 394.55 Mn |
| Mar 31, 2024 | 419.59 Mn |
| Dec 31, 2023 | 306.66 Mn |
| Sep 30, 2023 | 195.48 Mn |
| Jun 30, 2023 | 182.63 Mn |
| Mar 31, 2023 | 164.88 Mn |
| Dec 31, 2022 | 187.90 Mn |
| Sep 30, 2022 | 212.63 Mn |
| Jun 30, 2022 | 223.17 Mn |
| Mar 31, 2022 | 234.18 Mn |
| Dec 31, 2021 | 252.86 Mn |
| Sep 30, 2021 | 269.87 Mn |
| Jun 30, 2021 | 285.50 Mn |